Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

NBIXNBIX
6 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in NEUROCRINE BIOSCIENCES INC

JPMORGAN CHASE & CO holds 5.4M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $700.5M as of 2026-Q1. The position was increased (+4.7% shares). NBIX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$700.5M

Current Shares

5.4M

Total Value Change

+$513.3M

Total Shares Change

+4.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.4M
+4.7%
$700.5M0.0%$131.14
33
2025-Q4
Increased
5.2M
+9.9%
$737.6M0.0%$140.95
35
2025-Q3
Increased
4.7M
+11.0%
$664M0.0%$140.27
35
2025-Q2
Increased
4.3M
+59.6%
$535.7M0.0%$125.42
45
2025-Q1
Increased
2.7M
+94.8%
$295.4M0.0%$113.16
49
2024-Q4
New
1.4M
-
$187.2M0.0%$137.06
42

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used